The holobiont theory expands the notion of individual multicellular organisms as a community composed of a host and all its associated microorganisms. This concept has been extensively studied in the field of aquaculture, where increasing evidence has highlighted the importance of the host associated microorganisms in species fitness. Here, we focus our review on mollusc and crustacean species in which microbiota dysbiosis has recently been described in the context of various diseases, resulting in significant economic losses. Influencing the holobiont structure through the use of probiotics is a potential strategy that could improve the fitness or the robustness of cultivated species. We discuss here the possibility of developing microbiome targeted prophylactic approaches by promoting (1) methods to identify host microbial community that fosters good health status and (2) early life microbial education to favour long‐term resistance to stress or disease. This review aims to inform the aquaculture industry about potential strategies in rearing practices to mitigate diseases and economic losses.
18 March 2024 in Philosophical Transactions of the Royal Society B: Biological Sciences
The Pacific oyster Crassostrea gigas lives in microbe-rich marine coastal systems subjected to rapid environmental changes. It harbours a diversified and fluctuating microbiota that cohabits with immune cells expressing a diversified immune gene repertoire. In the early stages of oyster development, just after fertilization, the microbiota plays a key role in educating the immune system. Exposure to a rich microbial environment at the larval stage leads to an increase in immune competence throughout the life of the oyster, conferring a better protection against pathogenic infections at later juvenile/adult stages. This beneficial effect, which is intergenerational, is associated with epigenetic remodelling. At juvenile stages, the educated immune system participates in the control of the homeostasis. In particular, the microbiota is fine-tuned by oyster antimicrobial peptides acting through specific and synergistic effects. However, this balance is fragile, as illustrated by the Pacific Oyster Mortality Syndrome, a disease causing mass mortalities in oysters worldwide. In this disease, the weakening of oyster immune defences by OsHV-1 µVar virus induces a dysbiosis leading to fatal sepsis. This review illustrates the continuous interaction between the highly diversified oyster immune system and its dynamic microbiota throughout its life, and the importance of this cross-talk for oyster health. This article is part of the theme issue ‘Sculpting the microbiome: how host factors determine and respond to microbial colonization’.
Big defensins are two-domain antimicrobial peptides (AMPs) that have highly diversified in mollusks. Cg-BigDefs are expressed by immune cells in the oyster Crassostrea gigas, and their expression is dampened during the Pacific Oyster Mortality Syndrome (POMS), which evolves toward fatal bacteremia. We evaluated whether Cg-BigDefs contribute to the control of oyster-associated microbial communities. Two Cg-BigDefs that are representative of molecular diversity within the peptide family, namely Cg-BigDef1 and Cg-BigDef5, were characterized by gene cloning and synthesized by solid-phase peptide synthesis and native chemical ligation. Synthetic peptides were tested for antibacterial activity against a collection of culturable bacteria belonging to the oyster microbiota, characterized by 16S sequencing and MALDI Biotyping. We first tested the potential of Cg-BigDefs to control the oyster microbiota by injecting synthetic Cg-BigDef1 into oyster tissues and analyzing microbiota dynamics over 24 h by 16S metabarcoding. Cg-BigDef1 induced a significant shift in oyster microbiota β-diversity after 6 h and 24 h, prompting us to investigate antimicrobial activities in vitro against members of the oyster microbiota. Both Cg-BigDef1 and Cg-BigDef5 were active at a high salt concentration (400 mM NaCl) and showed broad spectra of activity against bacteria associated with C. gigas pathologies. Antimicrobial specificity was observed for both molecules at an intra- and inter-genera level. Remarkably, antimicrobial spectra of Cg-BigDef1 and Cg-BigDef5 were complementary, and peptides acted synergistically. Overall, we found that primary sequence diversification of Cg-BigDefs has generated specificity and synergy and extended the spectrum of activity of this peptide family.
The increase in marine diseases, particularly in economically important mollusks, is a growing concern. Among them, the Pacific oyster (Crassostrea gigas) production faces challenges from several diseases, such as the Pacific Oyster Mortality Syndrome (POMS) or vibriosis. The microbial education, which consists of exposing the host immune system to beneficial microorganisms during early life stages is a promising approach against diseases. This study explores the concept of microbial education using controlled and pathogen-free bacterial communities and assesses its protective effects against POMS and Vibrio aestuarianus infections, highlighting potential applications in oyster production. We demonstrate that it is possible to educate the oyster immune system by adding microorganisms during the larval stage. Adding culture based bacterial mixes to larvae protects only against the POMS disease while adding whole microbial communities from oyster donors protects against both POMS and vibriosis. The efficiency of immune protection depends both on oyster origin and on the composition of the bacterial mixes used for exposure. No preferential protection was observed when the oysters were stimulated with their sympatric strains. Furthermore, the added bacteria were not maintained into the oyster microbiota, but this bacterial addition induced long term changes in the microbiota composition and oyster immune gene expression. Our study reveals successful immune system education of oysters by introducing beneficial microorganisms during the larval stage. We improved the long-term resistance of oysters against critical diseases (POMS disease and Vibrio aestuarianus infections) highlighting the potential of microbial education in aquaculture.
Introduction: Oyster farming is a significant industry worldwide, but it is threatened by various diseases such as Pacific Oyster Mortality Syndrome or vibriosis. V. aestuarianus is a major cause of mortality for market-size oysters, resulting in significant economic losses for oyster farmers. Among the various control methods developed, probiotics appear to be a promising approach. More specifically, the use of the antibacterial activity of bacteria from the natural microbiota of the oyster Magallana gigas appears to be a sustainable solution against V. aestuarianus infections. Results: Our study investigated the probiotic potential of bacteria isolated from the microbiota of M. gigas oysters. We screened a collection of 334 bacteria against eight target pathogens, including V. aestuarianus , and identified 78 bacteria with antibacterial activity for which eight retained this activity in their culture supernatants. Five strains were selected for further testing and exposed to oysters prior to V. aestuarianus infection. Our results show that four strains significantly reduced oyster mortality, with a maximum reduction of 70%. In addition, changes in oyster microbiota composition were observed following exposure, but the administered bacteria were not detected in the microbiota. Conclusion: Our findings demonstrate the potential of oyster microbiota-derived bacteria as probiotics for disease control in oyster farming. This approach could provide a sustainable and environmentally friendly solution for the oyster farming industry. Further research is needed to understand the underlying mechanisms and to develop effective probiotic-based strategies for preventing V. aestuarianus infection.
Récemment, la fréquence et la gravité des maladies marines ont augmenté en lien avec les changementsenvironnementaux, et les mollusques d'intérêt économique sont particulièrement concernés. Un exemple frappant de maladie dévastatrice est lesyndrome de mortalité des huîtres du Pacifique (Pacific Oyster Mortality Syndrom ou POMS) causé par l'Ostreid Herpesvirus-1 μVar (OsHV-1μVar) qui est apparu en 2008 et qui a un impact considérable sur la production de Crassostrea gigas dans le monde entier en affectant les huîtresjuvéniles. Les huîtres adultes sont également touchées par des maladies infectieuses, en particulier celles causées par la bactérie pathogène Vibrioaestuarianus.Dans le cadre de mon doctorat, j'ai étudié la possibilité de tirer profit de l'effet bénéfique du microbiote de l'huître pour lutter contreces maladies infectieuses. Il a été rapporté que certaines souches bactériennes sont préférentiellement associées aux huîtres ayant une meilleurecapacité de survie à la maladie POMS. En outre, des travaux antérieurs ont montré qu'il était possible d'éduquer le système immunitaire deshuîtres en les exposant à un microbiote sain au cours de leur développement larvaire. Cette expérience a été réalisée en utilisant des huîtresdonneuses de microbiote. Cette éducation microbienne présentait l'avantage d'utiliser tout le potentiel de la diversité des micro-organismes, maisles communautés transférées n'étaient pas entièrement contrôlées et pouvaient donc présenter un risque de transmission de maladie infectieuse.Cette exposition au microbiote entier n'est donc pas applicable en aquaculture. C'est pourquoi j'ai décidé de concentrer mon travail sur unenvironnement microbien contrôlé et d'étudier ses effets bénéfiques potentiels sur la santé des huîtres.J'ai pour cela généré une collection debactéries provenant d'huître C. gigas collectées sur le terrain et naturellement résistantes aux maladies et j'ai caractérisé leurs effets sur les huîtres.Deux stratégies potentiellement bénéfiques ont été étudié :(1) J'ai réalisé une éducation microbienne du système immunitaire de l'huître enajoutant des mélanges bactériens multi-souches pendant le développement larvaire et j'ai étudié l'effet à long terme de cette exposition aux stadesjuvénile et adulte lors d'une infection à OsHV-1 et V. aestuarianus. (2) J'ai identifié des souches bactériennes produisant des composésantibactériens et j'ai étudié leurs effets à court terme en les administrant à des huîtres juvéniles et adultes juste avant la contamination par desagents pathogènes.Ces résultats ouvrent de nouvelles voies pour le développement d'approches prophylactiques ciblées sur le microbiote afind'atténuer les maladies dans l'ostréiculture.